The Plausible Mechanism Pathway allows FDA drug approval without randomized trials, focusing on diseases with known biological causes. This pathway targets rare genetic diseases, emphasizing biologic ...
Triple-negative breast cancer is one of the most aggressive and difficult cancers to treat. It can initially respond well to therapeutic combinations of chemotherapy, but a tiny minority of tumor ...
When 25-year-old Patrick Joseph Frawley Jr. went into the ball-point-pen business in 1949, he could not have picked a worse time. The market was flooded with pens; bankers warned against writing ...
The Verge’s favorite lower-tech productivity tools. The Verge’s favorite lower-tech productivity tools. Considering all the tech that we cover here at The Verge, you’d think that the members of our ...
ORLANDO, Fla. – Stylophiles, artists and writers looking for inspiration may find it at the Orlando Pen Show. The annual convention for all things pens, stationery, journaling and sketching returns to ...
Roche’s Genentech unit has handed over $20 million in upfront cash for the license to Omass Therapeutics’ preclinical inflammatory bowel disease (IBD) program. The program is the product of Omass’ ...
Autophagy is a natural, conserved process where cells degrade and recycle their own components, including damaged proteins and organelles. This targeted removal is orchestrated by cargo receptors, ...
A little boy from Colerain Township is making a big difference.He donated hundreds of dollars to a local animal shelter, using money he raised by making and selling pens. Nine-year-old Brody Baldwin ...
Actors James Stewart as Detective John 'Scottie' Ferguson and Kim Novak as Madeleine Elster in a publicity still for the film 'Vertigo', directed by Alfred Hitchcock, 1958. While pens are often ...
Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio. Oligonucleotides work as short ...
Binance announced on March 12 that its Alpha platform has implemented a new comprehensive token review framework that will aim to remove tokens that don’t meet certain quantitative and qualitative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results